Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation

Journal of Laboratory and Clinical Medicine

Volumn 146, Issue 4, 2005, Pages 216-226

  Hsiao, George ^a   Wang, Ying ^a   Tzu, Nien Hsuan ^a   Fong, Tsorng Hang ^a   Shen, Ming Yi ^a   Lin, Kuang Hung ^a   Chou, Duen Suey ^a   Sheu, Joen Rong ^a,b  

^a Graduate Institute of Microbiology   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COLLAGEN; CYCLIC GMP; FLUORESCEIN SODIUM; FURA 2; INOSITOL; LYCOPENE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; THROMBOCYTE RECEPTOR; THROMBOXANE B2;

ARTICLE; CALCIUM TRANSPORT; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR TRANSPORT; IRRADIATION; LATENT PERIOD; MESENTERY BLOOD VESSEL; PROTEIN PHOSPHORYLATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS; VENULE;

ANIMALS; ANTIOXIDANTS; BLOOD PLATELETS; BLOOD PROTEINS; CARCINOGENS; CAROTENOIDS; CYCLIC AMP; CYCLIC GMP; HUMANS; MICE; MICROCIRCULATION; NITRATES; PHORBOL 12,13-DIBUTYRATE; PHOSPHATIDYLINOSITOLS; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOSIS; THROMBOXANE B2;

EID: 25444518771     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.03.018     Document Type: Article

References (25)

1. J.H. Weisburger Lycopene and tomato products in human promotion Exp Biol Med 227 2002 924 927
2. P. Di Mascio, S. Kaiser, H. Sies Lycopene as the most efficient biological carotenoid singlet oxygen quencher Arch Biochem Biophys 274 1989 532 538
3. L. Kohlmeier, S.B. Hastinhs Epidemiological evidence of a role of carotenoids in cardiovascular disease prevention Am J Clin Nutr 62 suppl 1995 1370S 1376S
4. L. Arab, S. Steck Lycopene and cardiovascular disease Am J Clin Nutr 71 suppl 2000 1691S 1695S
5. P.H. Gann, J. Ma, E. Giovannucci, W. Willett, F.M. Sacks, C.H. Hennekens, M.J. Stampfer Lower prostate cancer risk in men with elevated plasma lycopene levels results of a prospective analysis Cancer Res 59 1999 1225 1230
6. M.D. Schleinitz, J.P. Weiss, D.K. Owens Clopidogrel versus aspirin for secondary prophylaxis of vascular events a cost-effectiveness analysis Am J Med 116 2004 797 806
7. J.R. Sheu, S.H. Chao, M.H. Yen, T.F. Huang In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice Thromb Haemost 72 1994 617 621
8. J.R. Sheu, C.R. Lee, C.C. Lin, Y.C. Kan, C.H. Lin, W.C. Hung, Y.M. Lee, M.H. Yen The antiplatelet activity of PMC, a potent α-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase Br J Pharmacol 127 1999 1206 1212
9. J.R. Sheu, C.H. Lin, C.H. Peng, T.F. Huang Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix protein via binding to multiple integrin receptors expressed on human hepatoma cells Proc Soc Exp Biol Med 213 1996 71 79
10. T.F. Huang, J.R. Sheu, C.M. Teng Mechanism of action of a potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom Thromb Haemost 66 1991 489 493
11. +2 indicator with greatly improved fluorescence properties J Biol Chem 260 1985 3440 3450
12. J.R. Sheu, W.C. Hung, C.H. Su, C.H. Lin, L.W. Lee, Y.M. Lee The antiplatelet activity of Escherichia coli lipopolysaccharide, is mediated through nitric oxide/cyclic GMP pathway Eur J Haematol 62 1999 317 326
13. J. Grabarek, M. Raychowdhury, K. Ravid, K.C. Kent, P.J. Newman, J.A. Ware Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells J Biol Chem 267 1992 10011 10017
14. J.R. Sheu, C.R. Lee, G. Hsiao, W.C. Hung, Y.M. Lee, Y.C. Chen Comparison of the relative activities of α-tocopherol and PMC on platelet aggregation and antioxidative activity Life Sci 65 1999 197 206
15. J.R. Sheu, W.C. Hung, C.H. Wu, M.C. Ma, Y.C. Kan, C.H. Lin Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia Circulation 99 1999 3056 3062
16. M.J. Broekman, J.W. Ward, A.J. Marcus Phospholipid metabolism in phosphatidyl inositol, phosphatic acid and lysophospholipids J Clin Invest 66 1980 275 283
17. W. Siess, E.G. Lapetina Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism Biochem J 263 1989 377 385
18. C.J. Kirk, J.A. Creba, C.P. Downes, R.H. Michell Hormone-stimulated metabolism of inositol lipids and its relationship to hepatic receptor function Biochem Soc Transact 9 1981 377 379
19. M.J. Berridge Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol Biochem J 212 1983 249 258
20. 2 production Biochem Pharmacol 31 1982 1158 1160
21. M.L. McKean, J.B. Smith, W.J. Silver Formation of lysophosphatidylcholine in human platelets in response to thrombin J Biol Chem 256 1981 1522 1524
22. +2, phospholipid-dependent protein kinase associated with plasma membrane Nature 301 1983 621 623
23. T. Murohara, S.J. Parkinson, S.A. Waldman, A.M. Lefer Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C Arterioscler Thromb Vasc Biol 15 1995 2068 2075
24. L.J. McDonald, F. Murad Nitric oxide and cyclic GMP signaling Proc Soc Exp Biol Med 211 1996 1 6
25. J. Loscalzo Nitric oxide insufficiency, platelet activation, and arterial thrombosis Circ Res 88 2001 756 762